Farah Ollaik
Papers
1
Total Citations
12
H-Index
1
About
Dr. Farah Ollaik is a clinician-researcher whose work sits at the critical intersection of head and neck surgical oncology and evidence-based treatment decision-making. Her primary research focus is on optimizing therapeutic strategies for oropharyngeal squamous cell carcinoma (OPSCC), with a particular emphasis on comparing the efficacy and functional outcomes of transoral robotic surgery (TORS) versus intensity modulated radiation therapy (IMRT). Her most cited work, "Patient Selection for Surgery vs Radiotherapy for Early Stage Oropharyngeal Cancer" (2021, 12 citations), directly addresses a central dilemma in modern oncology: how to balance equivalent survival rates with quality of life and functional preservation. By systematically analyzing patient selection criteria for early-stage disease, Dr. Ollaik provides a crucial framework for clinicians navigating the choice between these two powerful modalities. Her contributions help move the field toward more personalized, risk-adapted treatment paradigms, ensuring that patients receive the intervention best suited to their tumor biology and individual circumstances. Through her rigorous comparative effectiveness research, Dr. Ollaik is shaping how we define "optimal" care in head and neck cancer.
Research Focus
Key Achievements
Top Papers
- 1